SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 52.08+1.9%1:41 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (4630)9/10/2001 12:47:16 PM
From: tom pope  Read Replies (1) of 52153
 
posting this here because the IDPH thread is not very lively. The market seems to be unimpressed. From Briefing

11:18 ET IDEC Pharm (IDPH) 58.86 +1.25 (+2.1%): FDA staff finds company's experimental cancer drug Zevalin was effective in treating certain types of non-Hodgkins lymphomas (NHLs) for which other therapies have failed. The drug will go before an FDA advisory panel tomorrow. (Reuters)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News